Triptolide ameliorates colonic fibrosis in an experimental rat model

Area of Science:

• Gastroenterology
• Pharmacology
• Immunology

Background:

• Triptolide exhibits anti-inflammatory and immunomodulatory effects.
• Its impact on intestinal fibrosis remains unexamined.
• Previous research suggests triptolide suppresses colonic myofibroblasts and benefits Crohn's disease.

Purpose of the Study:

• To investigate the potential of triptolide in ameliorating colonic fibrosis.
• To determine if triptolide affects extracellular matrix deposition and collagen production in a rat model.

Main Methods:

• Colonic fibrosis was induced in rats using 2,4,6-trinitrobenzene sulfonic acid (TNBS).
• Triptolide or PBS was administered daily concurrently with TNBS.
• Extracellular matrix deposition was assessed via Masson Trichrome staining.
• Total collagen, Collagen Iα1 transcripts, and Collagen I protein were quantified.

Main Results:

• Triptolide treatment significantly decreased extracellular matrix deposition in the colon.
• Triptolide reduced total collagen levels and inhibited collagen production in colonic myofibroblasts.
• The compound suppressed Collagen Iα1 transcript and Collagen I protein expression.

Conclusions:

• Triptolide effectively ameliorates experimental colonic fibrosis in rats.
• Triptolide demonstrates potential as a therapeutic agent for inflammatory bowel disease, specifically targeting fibrosis.